Bactiquant AS Cash Flow Conversion Efficiency

Latest as of December 2025: -0.164x

Bactiquant AS cash flow conversion efficiency. Based on the latest financial reports, Bactiquant AS (BACTIQ) has a cash flow conversion efficiency ratio of -0.164x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr-2.84 Million ≈ $-443.77K USD) by net assets (Dkr17.26 Million ≈ $2.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Bactiquant AS (2019–2025)

Cash flow conversion efficiency of Bactiquant AS from 2019 to 2025. This chart illustrates how Bactiquant AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Bactiquant AS stock price for real-time trading data and today's change.

Bactiquant AS Cash Flow Conversion Ratio Explained

Bactiquant AS cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Bactiquant AS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bactiquant AS ranked by their cash flow conversion efficiency. Also see BACTIQ market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Samjin LND Co. Ltd KQ:054090	0.065x
Hindcon Chemicals Limited NSE:HINDCON	0.047x
Pinnacle Food Group Limited Class A Common Shares NASDAQ:PFAI	N/A
Asuransi Ramayana Tbk JK:ASRM	-0.017x
Mobilia Holdings Bhd KLSE:0229	0.061x
Close the Loop Ltd AU:CLG	0.019x
Heart Test Laboratories Inc. Common Stock NASDAQ:HSCS	648.679x
Century Extrusions Limited NSE:CENTEXT	0.095x

Annual Cash Flow Conversion Efficiency for Bactiquant AS (2019–2025)

The table below shows the annual cash flow conversion efficiency of Bactiquant AS from 2019 to 2025. Review how financially flexible is Bactiquant AS to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Dkr17.26 Million ≈ $2.70 Million	Dkr-10.51 Million ≈ $-1.64 Million	-0.609x	+96.68%
2024-12-31	Dkr689.23K ≈ $107.84K	Dkr-12.63 Million ≈ $-1.98 Million	-18.326x	-3136.99%
2023-12-31	Dkr14.41 Million ≈ $2.25 Million	Dkr-8.16 Million ≈ $-1.28 Million	-0.566x	+52.62%
2022-12-31	Dkr14.31 Million ≈ $2.24 Million	Dkr-17.10 Million ≈ $-2.67 Million	-1.195x	-89.96%
2021-12-31	Dkr21.06 Million ≈ $3.30 Million	Dkr-13.25 Million ≈ $-2.07 Million	-0.629x	-7751.79%
2020-12-31	Dkr8.97 Million ≈ $1.40 Million	Dkr-71.83K ≈ $-11.24K	-0.008x	+95.62%
2019-12-31	Dkr10.83 Million ≈ $1.69 Million	Dkr-1.98 Million ≈ $-309.47K	-0.183x	--

About Bactiquant AS

CO:BACTIQ Denmark Pollution & Treatment Controls

Market Cap

$14.74 Million

Dkr94.18 Million DKK

Market Cap Rank

#25913 Global

#118 in Denmark

Share Price

Dkr2.51

Change (1 day)

+3.29%

52-Week Range

Dkr2.05 - Dkr3.95

All Time High

Dkr19.55